[PMID]: | 28408039 |
[Au] Autor: | Musch DC; Niziol LM; Gillespie BW; Lichter PR; Janz NK |
[Ad] Endereço: | Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan; Department of Epidemiology, University of Michigan, Ann Arbor, Michigan. Electronic address: dmusch@med.umich.edu. |
[Ti] Título: | Binocular Measures of Visual Acuity and Visual Field versus Binocular Approximations. |
[So] Source: | Ophthalmology;124(7):1031-1038, 2017 Jul. |
[Is] ISSN: | 1549-4713 |
[Cp] País de publicação: | United States |
[La] Idioma: | eng |
[Ab] Resumo: | PURPOSE: To assess the relationship of binocular visual function tests with binocular approximations using data from the Collaborative Initial Glaucoma Treatment Study (CIGTS). DESIGN: Case series based on existing data from a clinical trial. PARTICIPANTS: Six hundred seven patients with newly diagnosed open-angle glaucoma from the CIGTS. METHODS: Monocular visual field (VF) and visual acuity (VA) tests were performed at baseline and every 6 months thereafter. Binocular tests of visual function (Esterman VF score, binocular VA) were added to the CIGTS protocol 3 years into the study. The binocular approximations of binocular visual function were better or worse eye, average eye, better or worse location, and binocular summation or pointwise binocular summation. Associations between binocular tests and binocular approximations to represent binocular visual function were assessed with Pearson's correlations (r), as was the relationship between vision-related quality of life (VR QOL; Visual Activities Questionnaire [VAQ] and the 25-item National Eye Institute Visual Function Questionnaire [NEI VFQ-25]) and binocular tests or binocular approximations of visual function. MAIN OUTCOME MEASURES: Binocular visual function (VF and VA) and VR QOL. RESULTS: Five hundred seventy-five patients underwent at least 1 binocular visual function test. The Esterman score was correlated significantly with all binocular approximations of VF, with r values ranging from 0.31 (worse-eye mean deviation [MD]) to 0.42 (better-eye MD; P < 0.0001 for all). Binocular VA showed stronger correlations with binocular approximations, with r values ranging from 0.65 (worse-eye VA) to 0.80 (binocular summation; P < 0.0001 for all). Correlations between the VAQ and Esterman score were stronger in 7 of 9 subscales (r = -0.14 to -0.25; P < 0.05 for all) than correlations with all 7 binocular approximations. In contrast, correlations between the VAQ and binocular VA (r = -0.07 to -0.21) were weaker in all subscales than those with better-eye, average-eye, and binocular summation of VA (r = -0.12 to -0.25), but not different from worse-eye values. These trends also were found in relevant subscales of the NEI VFQ-25. CONCLUSIONS: We found limited benefit in binocular testing of VA in the clinical setting as a means of approximating a patient's reported visual functioning. In contrast, we found some benefit in performing binocular VF testing, because the results correlated more closely with reported functioning than binocular approximations. |
[Mh] Termos MeSH primário: |
Glaucoma de Ângulo Aberto/fisiopatologia Visão Binocular/fisiologia Acuidade Visual Campos Visuais/fisiologia
|
[Mh] Termos MeSH secundário: |
Adulto Idoso Anti-Hipertensivos/administração & dosagem Estudos Transversais Feminino Cirurgia Filtrante/métodos Seguimentos Glaucoma de Ângulo Aberto/diagnóstico Glaucoma de Ângulo Aberto/terapia Seres Humanos Pressão Intraocular Masculino Meia-Idade Soluções Oftálmicas Qualidade de Vida Inquéritos e Questionários Fatores de Tempo Testes Visuais Visão Monocular/fisiologia
|
[Pt] Tipo de publicação: | JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL |
[Nm] Nome de substância:
| 0 (Antihypertensive Agents); 0 (Ophthalmic Solutions) |
[Em] Mês de entrada: | 1707 |
[Cu] Atualização por classe: | 170721 |
[Lr] Data última revisão:
| 170721 |
[Sb] Subgrupo de revista: | IM |
[Da] Data de entrada para processamento: | 170415 |
[St] Status: | MEDLINE |
|
|